GR1002486B - Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της. - Google Patents

Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της.

Info

Publication number
GR1002486B
GR1002486B GR880100850A GR880100850A GR1002486B GR 1002486 B GR1002486 B GR 1002486B GR 880100850 A GR880100850 A GR 880100850A GR 880100850 A GR880100850 A GR 880100850A GR 1002486 B GR1002486 B GR 1002486B
Authority
GR
Greece
Prior art keywords
ciclosporin
crystal form
new
production
compositions containing
Prior art date
Application number
GR880100850A
Other languages
Greek (el)
English (en)
Other versions
GR880100850A (el
Inventor
Danielle Dr. Giron
Hans Peter Dr. Weber
Yasuyuki Uike
Martin Dr. List
Friedrich Dr. Richter
Original Assignee
Novartis Ag (Novartis Sa) (Novartis Inc.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag (Novartis Sa) (Novartis Inc.) filed Critical Novartis Ag (Novartis Sa) (Novartis Inc.)
Publication of GR880100850A publication Critical patent/GR880100850A/el
Publication of GR1002486B publication Critical patent/GR1002486B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
GR880100850A 1987-12-21 1988-12-20 Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της. GR1002486B (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13623087A 1987-12-21 1987-12-21
US17261388A 1988-03-24 1988-03-24
US21254888A 1988-06-28 1988-06-28

Publications (2)

Publication Number Publication Date
GR880100850A GR880100850A (el) 1994-03-31
GR1002486B true GR1002486B (el) 1996-12-09

Family

ID=27384838

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100850A GR1002486B (el) 1987-12-21 1988-12-20 Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της.

Country Status (27)

Country Link
JP (1) JPH0791316B2 (fr)
KR (1) KR100188305B1 (fr)
AT (1) AT403163B (fr)
AU (1) AU626274B2 (fr)
BE (1) BE1002665A4 (fr)
CA (1) CA1341396C (fr)
CH (1) CH677926A5 (fr)
CY (1) CY1799A (fr)
DE (1) DE3843054C2 (fr)
DK (1) DK175220B1 (fr)
ES (1) ES2012580A6 (fr)
FI (1) FI89065C (fr)
FR (1) FR2624863B1 (fr)
GB (1) GB2211848B (fr)
GR (1) GR1002486B (fr)
HK (1) HK102894A (fr)
HU (1) HU203564B (fr)
IE (1) IE62006B1 (fr)
IL (1) IL88719A0 (fr)
IT (1) IT1235356B (fr)
LU (1) LU87409A1 (fr)
MY (1) MY103943A (fr)
NL (1) NL195096C (fr)
NO (1) NO177228C (fr)
NZ (1) NZ227384A (fr)
SE (1) SE503174C2 (fr)
SG (1) SG99494G (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US5294604A (en) * 1989-12-20 1994-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating ocular diseases by periocular administration of cyclosporine A or G
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US6262054B1 (en) 1996-02-01 2001-07-17 Sloan-Kettering Institute Of Cancer Research Combination therapy method for treating breast cancer using edatrexate
AU737053B2 (en) 1997-01-30 2001-08-09 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
TW581681B (en) 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
CA2553381C (fr) 2004-01-20 2011-03-22 Allergan, Inc. Compositions pour traitement local de l'oeil, comprenant de preference de l'acetonide de triamcinolone et de l'acide hyaluronique
CN1763084B (zh) * 2005-10-11 2010-04-21 山东新时代药业有限公司 高纯度环孢菌素a的制备方法
MY180581A (en) 2011-05-27 2020-12-02 Allergan Inc A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
CN104080442B (zh) * 2011-11-15 2018-01-05 阿勒根公司 环孢菌素a形式2的悬浮液
AU2012339701B8 (en) * 2011-11-15 2017-11-16 Allergan, Inc. Autoclavable suspensions of cyclosporin A Form 2
RU2639393C2 (ru) 2011-11-15 2017-12-21 Аллерган, Инк. Состав пролонгированного действия циклоспорина формы 2
EP2780358B1 (fr) * 2011-11-15 2016-03-23 Allergan, Inc. Forme 2 de la cyclosporine et procédé pour sa préparation
TW202430537A (zh) * 2022-10-20 2024-08-01 日商中外製藥股份有限公司 環狀胜肽的結晶的製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (fr) * 1975-11-04 1979-12-28 Sandoz Ag
CH640519A5 (en) * 1976-04-09 1984-01-13 Sandoz Ag Process for preparing a modified form of the antibiotic S 7481/F-1
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
CH637124A5 (en) * 1978-10-18 1983-07-15 Sandoz Ag Antibiotic, its preparation and use

Also Published As

Publication number Publication date
AT403163B (de) 1997-11-25
KR100188305B1 (ko) 1999-06-01
FI89065C (fi) 1993-09-30
FI885869L (fi) 1989-06-22
FI89065B (fi) 1993-04-30
MY103943A (en) 1993-10-30
GB8829556D0 (en) 1989-02-08
IT8848690A0 (it) 1988-12-20
DK705488D0 (da) 1988-12-19
SG99494G (en) 1994-10-28
IE62006B1 (en) 1994-12-14
DE3843054C2 (de) 2003-08-21
CY1799A (en) 1995-02-17
HK102894A (en) 1994-09-30
BE1002665A4 (fr) 1991-04-30
KR890009975A (ko) 1989-08-05
ES2012580A6 (es) 1990-04-01
NZ227384A (en) 1991-09-25
CA1341396C (fr) 2002-11-05
SE8804570D0 (sv) 1988-12-19
IL88719A0 (en) 1989-07-31
JPH01211598A (ja) 1989-08-24
DK175220B1 (da) 2004-07-12
SE503174C2 (sv) 1996-04-15
CH677926A5 (fr) 1991-07-15
GB2211848B (en) 1991-11-06
JPH0791316B2 (ja) 1995-10-04
GR880100850A (el) 1994-03-31
AU2705588A (en) 1989-06-22
FR2624863B1 (fr) 1991-04-26
FI885869A0 (fi) 1988-12-19
DE3843054A1 (de) 1989-07-27
NO885625D0 (no) 1988-12-19
AU626274B2 (en) 1992-07-30
NL8803125A (nl) 1989-07-17
LU87409A1 (fr) 1989-07-07
DK705488A (da) 1989-06-22
FR2624863A1 (fr) 1989-06-23
NL195096C (nl) 2004-02-09
IE883779L (en) 1989-06-21
HU203564B (en) 1991-08-28
HUT49893A (en) 1989-11-28
NO885625L (no) 1989-06-22
SE8804570L (sv) 1989-06-22
ATA309588A (de) 1997-04-15
NO177228C (no) 1995-08-09
GB2211848A (en) 1989-07-12
IT1235356B (it) 1992-06-30
NO177228B (no) 1995-05-02

Similar Documents

Publication Publication Date Title
GR1002486B (el) Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της.
CA2000786A1 (fr) 3-piperidinyl-1,2-benzisoxazoles
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
IE891798L (en) Novel ó-glucosidase inhibitors
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
GEP20022636B (en) 4-[5-Methyl-3-Phenylisoxazol-4-Yl] Benzenesulfonamide, Its Crystal Structure B, Pharmaceutical Composition Containing The Same, Methods For Treatment Or Prophylaxis Of Disorders Caused By Cyclooxygen-2
UA35574C2 (uk) Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі
ATE330943T1 (de) Herstellungsverfahren von huperzine a und deren analogen und verbindungen nützlich dazu
HUT50347A (en) Process for production of cefalosporin-salts and injectable compositions containing them as active sobstance
MY107449A (en) Bcrf1 proteins as inhibitors of interferon- gamma.
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
EP0273310A3 (fr) 5-Aryl-3H-1,2,4-triazol-3-ones et leur emploi comme anticonvulsifs
WO1990007260A3 (fr) 2,3-methanoproline
GR3015132T3 (en) Novel ureas and thioureas, preparation thereof and application in therapy.
ES8300475A1 (es) Un procedimiento para la preparacion de un alergeno
ES8204713A1 (es) Un procedimiento para aislar un polipeptido purificado
AU578125B2 (en) Pyrazine diazohydroxide compounds
MY103584A (en) 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
GEP20002095B (en) Antracycline Disaccharides, Process for Their Preparation and Pharmaceutical Compositions
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
UA26922C2 (uk) Похідhі сульфамідосульфоhілсечовиhи, що мають гербіцидhу активhість,та гербіцидhа композиція hа їх осhові

Legal Events

Date Code Title Description
MA Right expired